Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply

Autor: Gao, Zhen, Huang, Shujie, Wang, Sichao, Tang, Dezhao, Xu, Wei, Zeng, Ruijie, Qiao, Guibin
Zdroj: In The Lancet Regional Health - Western Pacific October 2023 39
Databáze: ScienceDirect